UProtech Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 3

UProtech General Information

Description

Producer of protein degradation drug development in Hangzhou, China. The company focuses on developing next-generation protein-degrading drugs, providing patients with autoimmune disease drug.

Contact Information

Website
u-protech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Building 1, Huoshui Industrial Park
  • No. 95, Binwen Road, Binjiang District
  • Hangzhou, Zhejiang
  • China
+86 166
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3rd Floor, Building 1, Huoshui Industrial Park
  • No. 95, Binwen Road, Binjiang District
  • Hangzhou, Zhejiang
  • China
+86 166

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

UProtech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 02-Sep-2022 Completed Startup
To view UProtech’s complete valuation and funding history, request access »

UProtech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shanghai Healthcare Capital PE/Buyout Minority
Shangshi Venture Investment Corporate Venture Capital Minority
Zheshang Venture Capital Venture Capital Minority
To view UProtech’s complete investors history, request access »

UProtech FAQs

  • When was UProtech founded?

    UProtech was founded in 2021.

  • Where is UProtech headquartered?

    UProtech is headquartered in Hangzhou, China.

  • What industry is UProtech in?

    UProtech’s primary industry is Drug Discovery.

  • Is UProtech a private or public company?

    UProtech is a Private company.

  • What is UProtech’s current revenue?

    The current revenue for UProtech is .

  • Who are UProtech’s investors?

    Shanghai Healthcare Capital, Shangshi Venture Investment, and Zheshang Venture Capital have invested in UProtech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process